ABSTRACT
La papulosis fibrosa blanca del cuello es una patología benigna, que se presenta frecuentemente en personas mayores y que se caracteriza por pápulas blanquecinas ubicadas habitualmente en las regiones laterales del cuello. El hallazgo histopatológico distintivo es el incremento de las fibras de colágeno en la dermis papilar. Su etiopatogenia es, hasta ahora, desconocida y su tratamiento es difícil. Dado que corresponde a una patología infrecuente, probablemente subdiagnosticada, es que se decide reportar el caso de una mujer chilena de 77 años.
White fibrous papulosis of the neck is a benign pathology, which usually occurs in old people and is characterized by whitish papules that are frequently located in the lateral regions of the neck. The distinctive histopathological finding is the increase of collagen fibers in the papillary dermis. Its pathophysiology is not currently known and its treatment is difficult. Due to being a rare pathology, probably underdiagnosed, it was decided to report the case of a 77-yearold chilean woman.
Subject(s)
Humans , Female , Aged , Skin Aging/pathology , Skin Diseases, Papulosquamous/pathology , Neck/pathology , Biopsy , Diagnosis, DifferentialABSTRACT
Summary: Heart Disease is the leading cause of death among women in Chile. It appears at younger ages than most people think and the risk increases during aging. Although mortality has declined in men in recent years, women have increased. Cardiovascular risk factors, including menopause, are critical in atherogenesis, and explained 90 percent of heart attacks in women, and greater morbimortality. Cardiovascular risk factors, differently affect men and women. In turn, mortality from cardiovascular disease increases with the number of risk factors, which increase after menopause, especially obesity, hypertension and dyslipidemia, which could be associated with metabolic factors mediated by hormonal changes. Framingham tables underestimate the risk of women classified as 90 percent of women at low risk and very few at high risk before age 70. The recommendations are appropriate management of cardiovascular risk factors to prevent atherosclerosis, with a thorough individual risk assessment to identify women at risk. Hormone replacement therapy is not indicated as cardiovascular prevention.